Preparatory and ChEMBL/EVA Bridge

Wellcome and EMBL-EBI seek to establish a partnership to deliver molecular biology open data resources that enable both basic research and translational innovation to improve human health. It is clear that in the future, the open data resources at EMBL-EBI - on which the world depends - need to be built even more fairly and inclusively to maximise the impact of research. The multifaceted challenge of improving human health on a global scale will need concurrence and collaboration among diverse stakeholders from multiple geographic regions, requiring a renewed approach to data resource development, capacity building and delivery. This proposal comes in two parts over two years starting 2 January 2024: Part 1. Preparatory phase. To enable EBI and Wellcome to explore together new ways to build life science data infrastructure that is truly global. This will combine agile resource development and networking to improve the global reach of data services. Part 2. Bridging. To maintain European Variation Archive (EVA) and ChEMBL, including pilot work for more global approaches to engagement and coordination. This will prototype a funding model for resource delivery in the future, allowing strategic adjustments across the EMBL-EBI portfolio to meet new operational opportunities globally.